)
China Life Insurance Company (2628) investor relations material
China Life Insurance Company Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
9M 2026 gross written premiums rose 1.0% YoY to RMB676,144 million; new business value increased 13.1% YoY, while adjusted net profit rose 15.8% to RMB94,220 million.
Reported net profit attributable to equity holders fell 46.7% YoY to RMB89,430 million, amid capital-market volatility and a high comparison base.
Total assets reached RMB8,152,647 million, up 7.4% from year-end 2025; core and comprehensive solvency ratios were 156.29% and 197.56%.
Financial highlights
9M operating income was RMB367,812 million, down 31.6% YoY; operating profit was RMB94,636 million versus RMB204,954 million.
9M net profit was RMB91,329 million versus RMB169,780 million; attributable net profit was RMB89,430 million versus RMB167,804 million.
Basic and diluted EPS were RMB3.16, down 46.7% YoY; weighted-average ROE was 14.16%, down 15.11 percentage points.
9M operating cash inflow was RMB394,990 million, down 1.2% YoY.
Outlook and guidance
Priorities include deepening asset-liability interaction, expanding healthcare and senior-care ecosystem development, advancing digital-intelligent transformation, and strengthening risk prevention and control.
Strategic aim is to build comprehensive strength and pursue a strong start to the 15th Five-Year Plan period.
- Insurance revenue and new business value grew amid pandemic disruption, while net profit declined.2628
Q1 2020 - Net profit surged 228.6% year-over-year to RMB134,489 million, with strong premium and asset growth.2628
H1 2026 - Net profit dropped 32.3% year-over-year despite record growth in new business premiums.2628
Q1 2026 - Net profit surged 44.1% to RMB154.1 billion, with record assets and robust premium growth.2628
H2 2025 - Net profit rose 60.5% year-over-year, driven by strong premium and investment income growth.2628
Q3 2025 - Net profit surged 39.5% year-over-year, with premiums and solvency ratios both rising.2628
Q1 2025 - Record premiums and profit growth, high solvency, and interim dividend proposed.2628
H1 2025 - Net profit soared 173.9% year-over-year on record premiums and strong investment returns.2628
Q3 2024 - Net profit rose 5.9% to RMB38.3 billion as premiums and embedded value reached record highs.2628
H1 2024
)
)
)
)
)
)
)
)